Background/Aims: Ten-day sequential therapy has been evaluated as the first line therapy for Helicobacter pylori eradication but studies on sequential therapy as a second line therapy is lacking. The aim of this study was to compare the efficacy of 10-day sequential therapy and quadruple therapy as second line treatment for H. pylori eradication after failure of standard triple therapy. Methods: Patients who did not respond to standard triple therapy for H. pylori eradication were assigned to either 10-day sequential or bismuth based quadruple therapy as second line treatment from
대상 및 방법 
＜0.001
Values are presented as mean±SD, n (%), or n only. EGC, early gastric cancer; MALT, mucosa associated lymphoid tissue. 결 과 
김승범 등. H. pylori 이차 제균 치료로서 10일 순차 치료의 효과
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